AmplifyBio Chooses Blue Mountain to Achieve GMP Compliance and Advance Digital Strategy
December 01, 2022 09:30 ET
|
AmplifyBio
WEST JEFFERSON, Ohio, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Amplify Bio has selected Blue Mountain Regulatory Asset Manager (RAM) to help with incorporating industry best practices and ensuring...
AmplifyBio Announces Completion of Initiatives to Expand Vivarium Capacity
November 10, 2022 06:00 ET
|
AmplifyBio
WEST JEFFERSON, Ohio, Nov. 10, 2022 (GLOBE NEWSWIRE) -- AmplifyBio, a contract research organization that is building an ecosystem for the advancement of advanced therapies, today announced the...
AmplifyBio Celebrates One Year Since Launch With an Expansion of Capabilities and Capacity and a New Site
July 12, 2022 09:00 ET
|
AmplifyBio
WEST JEFFERSON, Ohio, July 12, 2022 (GLOBE NEWSWIRE) -- AmplifyBio spent the month of June commemorating the first anniversary since its spin-off from the Battelle organization. The celebration...
EVEON announces the launch of the European project INDENEO to develop an innovative delivery system for nose to brain administration of biological and advanced therapy drugs to neonates
July 07, 2022 03:49 ET
|
EVEON
EVEON, designer and manufacturer of medical devices for the preparation and delivery of drugs, announces the launch of a European consortium project INDENEO, for the Rare Disease Research (RDR)...
Global Gene Therapy R&D Market Worth US$ 22,685.70 Million by 2031: Visiongain Research Inc.
June 29, 2021 11:36 ET
|
Visiongain Ltd
Global Gene Therapy R&D Market Forecast 2021-2031: - Market Segment by Disease {Cancer, Rare Diseases (Oncologic, Non-Oncologic), Cardiovascular Diseases, Ophthalmic Diseases, Hematology,...
Anti-Ineffective Agents Market will Grow at CAGR of 4.3% by 2031: Visiongain Research Inc.
June 23, 2021 12:30 ET
|
Visiongain Ltd
Visiongain has published a new analysis of the Anti-Infective Agents Market from this year till 2031. It includes profiles of Anti-Infective Agents and Forecasts By Type (Antiviral, Antibacterial,...
NGS Based RNA Sequencing Market Worth US$ 6874 Million by 2031: Visiongain Research Inc.
June 22, 2021 12:00 ET
|
Visiongain Ltd
Visiongain has published a new report on Global NGS Based RNA Sequencing Market Report Forecast 2021-2031. Forecasts by component (Sequencing Platforms, Sequencing Products, Kits and Reagents,...
The Global Advanced Therapy Medicinal Products Market is projected to reach at market value of US$ 59.91 billion by 2031
June 02, 2021 09:00 ET
|
Visiongain Ltd
Visiongain has published a new report on Global Advanced Therapy Medicinal Products (ATMP) Market Report Forecast 2021-2031. Forecasts by Therapy Products ($ Bn), Plus Profiles of Leading ATMP...
Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability
June 18, 2020 06:30 ET
|
Emergent BioSolutions
Company acquires property adjacent to its Canton, Massachusetts live viral drug substance development and manufacturing facility to increase campus footprint and build out advanced therapy...
TrakCel to develop and supply Medeor Therapeutics with cellular supply chain management and orchestration system
September 12, 2018 08:00 ET
|
TrakCel
CARDIFF, United Kingdom, Sept. 12, 2018 (GLOBE NEWSWIRE) -- TrakCel, the cell and gene therapy supply chain tracking and orchestration system software developer, today announces it has been engaged...